Use of a kinase inhibitor for the treatment of thymoma

作者: Bernard Laffranchi , Angela Scaburri , Silvia Comis , Marina Ciomei , Maria Adele Pacciarini

DOI:

关键词:

摘要: The invention provides a low molecular weight ATP-competitive CDK inhibitor and TRKA of formula (I) for use in the treatment thymoma thymic carcinoma. compound can be administered together with one or more cytotoxic cytostatic agents.

参考文章(10)
Paolo Pevarello, Paola Vianello, Fulvia Roletto, Gabriella Traquandi, Francesca Quartieri, Achille Panzeri, Paolo Polucci, Ron Ferguson, Daniele Fancelli, Anna Vulpetti, Roberto d'Alessio, Maria Gabriella Brasca, Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors ,(2004)
Paolo Pevarello, Enrico Pesenti, Ciro Mercurio, Maria Grazia Porro, Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic ,(2007)
Kohei Yokoi, Haruhisa Matsuguma, Rie Nakahara, Tetsuro Kondo, Yukari Kamiyama, Kiyoshi Mori, Naoto Miyazawa, Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. Journal of Thoracic Oncology. ,vol. 2, pp. 73- 78 ,(2007) , 10.1097/JTO.0B013E31802BAFC8
Maria Gabriella Brasca, Nadia Amboldi, Dario Ballinari, Alexander Cameron, Elena Casale, Giovanni Cervi, Maristella Colombo, Francesco Colotta, Valter Croci, Roberto D’Alessio, Francesco Fiorentini, Antonella Isacchi, Ciro Mercurio, Walter Moretti, Achille Panzeri, Wilma Pastori, Paolo Pevarello, Francesca Quartieri, Fulvia Roletto, Gabriella Traquandi, Paola Vianello, Anna Vulpetti, Marina Ciomei, Identification of N,1,4,4-Tetramethyl-8-{[4-(4-Methylpiperazin-1-Yl)Phenyl]Amino}-4,5-Dihydro-1H-Pyrazolo[4,3-H]Quinazoline-3-Carboxamide (Pha-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor. Journal of Medicinal Chemistry. ,vol. 52, pp. 5152- 5163 ,(2009) , 10.1021/JM9006559
Kazuya Kondo, Optimal therapy for thymoma The Journal of Medical Investigation. ,vol. 55, pp. 17- 28 ,(2008) , 10.2152/JMI.55.17
Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, Jantien Wanders, Richard S. Kaplan, Larry Rubinstein, Jaap Verweij, Martine Van Glabbeke, Allan T. van Oosterom, Michaele C. Christian, Steve G. Gwyther, New Guidelines to Evaluate the Response to Treatment in Solid Tumors JNCI: Journal of the National Cancer Institute. ,vol. 92, pp. 205- 216 ,(2000) , 10.1093/JNCI/92.3.205
Eric A. Engels, Ruth M. Pfeiffer, Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. International Journal of Cancer. ,vol. 105, pp. 546- 551 ,(2003) , 10.1002/IJC.11099
Cameron D. Wright, Management of thymomas. Critical Reviews in Oncology Hematology. ,vol. 65, pp. 109- 120 ,(2008) , 10.1016/J.CRITREVONC.2007.04.005
Dae Joon Kim, Woo-Ick Yang, Se Hoon Kim, In-Kyu Park, Kyung Young Chung, Expression of neurotrophin receptors in surgically resected thymic epithelial tumors European Journal of Cardio-Thoracic Surgery. ,vol. 28, pp. 611- 616 ,(2005) , 10.1016/J.EJCTS.2005.06.034
Laszlo Revesz, Achim Schlapbach, Rudolf Walchli, Pyrrolo isoquinolines as kinase inhibitors ,(2007)